These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lacosamide on background eeg activity in brain tumor-related epilepsy patients: A case series study. Maschio M, Zarabla A, Maialetti A, Sperati F, Dinapoli L, Dispenza S, Petreri G, Cantelmi T. Brain Behav; 2018 Nov; 8(11):e01067. PubMed ID: 30334378 [Abstract] [Full Text] [Related]
5. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses? Brodie MJ, Kelly K, Stephen LJ. Epilepsy Behav; 2014 Feb; 31():73-6. PubMed ID: 24361766 [Abstract] [Full Text] [Related]
6. Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study. Mo F, Meletti S, Belcastro V, Quadri S, Napolitano M, Bello L, Dainese F, Scarpelli M, Florindo I, Mascia A, Pauletto G, Bruno F, Pellerino A, Giovannini G, Polosa M, Sessa M, Conti Nibali M, Di Gennaro G, Gigli GL, Pisanello A, Cavallieri F, Rudà R. J Neurooncol; 2022 May; 157(3):551-559. PubMed ID: 35397759 [Abstract] [Full Text] [Related]
10. Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy. Baulac M, Byrnes W, Williams P, Borghs S, Webster E, De Backer M, Dedeken P. Acta Neurol Scand; 2017 Apr; 135(4):434-441. PubMed ID: 27714769 [Abstract] [Full Text] [Related]
11. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy. Lancman ME, Fertig EJ, Trobliger RW, Perrine K, Myers L, Iyengar SS, Malik M. Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132 [Abstract] [Full Text] [Related]
12. Adjunctive lacosamide in clinical practice: sodium blockade with a difference? Stephen LJ, Kelly K, Parker P, Brodie MJ. Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421 [Abstract] [Full Text] [Related]
14. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study. Runge U, Arnold S, Brandt C, Reinhardt F, Kühn F, Isensee K, Ramirez F, Dedeken P, Lauterbach T, Noack-Rink M, Mayer T. Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971 [Abstract] [Full Text] [Related]
17. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs. Neal A, D'Souza W, Hepworth G, Lawn N, Cook M, Nikpour A. Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359 [Abstract] [Full Text] [Related]
18. A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures. Steinhoff BJ, Eckhardt K, Doty P, De Backer M, Brunnert M, Schulze-Bonhage A. Epilepsy Behav; 2016 May; 58():35-43. PubMed ID: 27054272 [Abstract] [Full Text] [Related]